Use of Platelet-Rich Plasma in the Management of Oral Biphosphonate-Associated Osteonecrosis of the Jaw: A Report of 2 Cases
Authors:
- Cameron Y. S. LeeCLCameron Y. S. Lee
- Teresa DavidTDTeresa David
- Michael NishimeMNMichael Nishime
- 1 December 2007
- journal article
- case report
- Published by American Academy of Implant Dentistry in Journal of Oral Implantology
- Vol. 33 (6) , 371-382
Abstract
Bisphosphonates (BP) are nonhormonal medications used in the treatment of various bone malignancies and metabolic conditions. Since 2003, there have appeared a significant and growing number of articles in the worldwide medical and dental literature describing the complication of an osteonecrosis of the jaws associated with the intravenous and, most recently, the oral form of BP medication that has been refractory to any definitive form of treatment. The authors have successfully managed 2 patients taking the oral form of BP with adjunctive treatment using platelet-rich plasma (PRP), and in one case with hyperbaric oxygen (HBO). We were able to obtain complete remission in each case, which is defined as resolution of pain and complete closure of exposed bone in the jaws. The purpose of this report is to describe a treatment protocol and the rationale for using PRP and HBO to obtain complete remission of this new pathologic condition.Keywords
This publication has 54 references indexed in Scilit:
- Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 casesInternational Journal of Oral and Maxillofacial Surgery, 2006
- Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapyThe Journal of the American Dental Association, 2005
- Bisphosphonate-associated osteonecrosis of the jawsThe Journal of the American Dental Association, 2005
- Managing the care of patients with bisphosphonate-associated osteonecrosisThe Journal of the American Dental Association, 2005
- Bisphosphonate Osteochemonecrosis (Bis-Phossy Jaw): Is This Phossy Jaw of the 21st Century?Journal of Oral and Maxillofacial Surgery, 2005
- Intravenous bisphosphonates and osteonecrosisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2004
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Osteogenesis imperfectaThe Lancet, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003
- Overview of bisphosphonatesCancer, 1997